Entheon Biomedical Corp. (TSE:ENBI) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Entheon Biomedical Corp., a biotech firm working on addiction and substance use disorders, has announced a private placement financing to raise up to CDN$147,500 through the sale of up to 2,950,000 Units. Each Unit includes a common share and a share purchase warrant, which can be exercised at CDN$0.10 per Share for five years. The funds raised will bolster the company’s general working capital.
For further insights into TSE:ENBI stock, check out TipRanks’ Stock Analysis page.